JBM (Healthcare)'s Profit Jumps 20% in Fiscal H1

MT Newswires Live11-18

JBM (Healthcare) (HKG:2161) recorded a 20% rise in attributable profit in six months ended Sept. 30 to HK$115 million from HK$95.9 million in the year-ago period, a Monday Hong Kong bourse filing said.

Shares of the drug company were up nearly 5% in Tuesday afternoon trading.

Earnings per share were HK$0.1412 in the half year, up from HK$0.1163 in the corresponding period of the last year.

Revenue rose 7.7% to HK$429.6 million in the interim period from HK$399 million a year prior, driven by a strong performance in the branded medicine and proprietary Chinese medicine segments.

The firm attributed the higher profit to a rise in profit from operations.

The company declared an interim dividend of HK$0.0975 per ordinary share, payable Dec. 17 to shareholders of record on Dec. 3.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2584985258?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-18 14:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584985258","market":"sh","top_or_hot":-1,"title":"JBM (Healthcare)'s Profit Jumps 20% in Fiscal H1","media":"MT Newswires Live","content":"<html><body><p> JBM (Healthcare) (HKG:2161) recorded a 20% rise in attributable profit in six months ended Sept. 30 to HK$115 million from HK$95.9 million in the year-ago period, a Monday Hong Kong bourse filing said.</p><p>Shares of the drug company were up nearly 5% in Tuesday afternoon trading.</p><p>Earnings per share were HK$0.1412 in the half year, up from HK$0.1163 in the corresponding period of the last year.</p><p>Revenue rose 7.7% to HK$429.6 million in the interim period from HK$399 million a year prior, driven by a strong performance in the branded medicine and proprietary Chinese medicine segments.</p><p>The firm attributed the higher profit to a rise in profit from operations.</p><p>The company declared an interim dividend of HK$0.0975 per ordinary share, payable Dec. 17 to shareholders of record on Dec. 3.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JBM (Healthcare)'s Profit Jumps 20% in Fiscal H1</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJBM (Healthcare)'s Profit Jumps 20% in Fiscal H1\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-18 14:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> JBM (Healthcare) (HKG:2161) recorded a 20% rise in attributable profit in six months ended Sept. 30 to HK$115 million from HK$95.9 million in the year-ago period, a Monday Hong Kong bourse filing said.</p><p>Shares of the drug company were up nearly 5% in Tuesday afternoon trading.</p><p>Earnings per share were HK$0.1412 in the half year, up from HK$0.1163 in the corresponding period of the last year.</p><p>Revenue rose 7.7% to HK$429.6 million in the interim period from HK$399 million a year prior, driven by a strong performance in the branded medicine and proprietary Chinese medicine segments.</p><p>The firm attributed the higher profit to a rise in profit from operations.</p><p>The company declared an interim dividend of HK$0.0975 per ordinary share, payable Dec. 17 to shareholders of record on Dec. 3.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2584985258","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584985258","pubTimestamp":1763447148,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"JBM   recorded a 20% rise in attributable profit in six months ended Sept. 30 to HK$115 million from HK$95.9 million in the year-ago period, a Monday Hong Kong bourse filing said.Shares of the drug company were up nearly 5% in Tuesday afternoon trading.Earnings per share were HK$0.1412 in the half year, up from HK$0.1163 in the corresponding period of the last year.Revenue rose 7.7% to HK$429.6 million in the interim period from HK$399 million a year prior, driven by a strong performance in the branded medicine and proprietary Chinese medicine segments.The firm attributed the higher profit to a rise in profit from operations.The company declared an interim dividend of HK$0.0975 per ordinary share, payable Dec. 17 to shareholders of record on Dec. 3.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","XLV":"健康照护类股ETF-SPDR","XBI":"SPDR S&P Biotech ETF","HCSG":"Healthcare Svcs Group Inc","LABU":"三倍做多标普生物-Direxion","BK4137":"综合支持服务","BK4588":"碎股","02161":"健倍苗苗","BK1606":"中医药概念","BK1191":"制药","BK4585":"ETF&股票定投概念","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC"},"translate_title":"JBM（医疗保健）上半年利润增长20%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1.5,"XBI":0.6,"02161":1,"XLV":1.5,"LABU":0.6},"content_text":"JBM (Healthcare) (HKG:2161) recorded a 20% rise in attributable profit in six months ended Sept. 30 to HK$115 million from HK$95.9 million in the year-ago period, a Monday Hong Kong bourse filing said.Shares of the drug company were up nearly 5% in Tuesday afternoon trading.Earnings per share were HK$0.1412 in the half year, up from HK$0.1163 in the corresponding period of the last year.Revenue rose 7.7% to HK$429.6 million in the interim period from HK$399 million a year prior, driven by a strong performance in the branded medicine and proprietary Chinese medicine segments.The firm attributed the higher profit to a rise in profit from operations.The company declared an interim dividend of HK$0.0975 per ordinary share, payable Dec. 17 to shareholders of record on Dec. 3.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584985258","isCrawlerRequest":true}